Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by Maui527on Dec 14, 2020 2:42pm
828 Views
Post# 32101514

Spoke To Robert!

Spoke To Robert!To All,

I just spoke to Robert, great conversation and welcomed all my questions!

He is as frustartted as we all are, as all has been submitted and he is also waiting for the halt to be removed. At this point there nothing more that KLY can as all has been filed properly and fines have been paid to the BSC, ASC and OSC. The hold up at this point has been discribed to me (as what has been told to Robert and the legal consel) is that the BSC, ASC and OSC are extremely back logged with staff working from remore locations (home). He is somewhat hopeful that the halt maybe be lifted this week, or next week at the latest! (fingers crossed)

As asked about new developments and yes there is some exciting developemnets and news to be announced, but not until after the halt has been lifted.

There you have it...don't shout the messenger!
<< Previous
Bullboard Posts
Next >>